EV71 vaccine: Protection from a previously neglected disease

The Lancet

Volumn 381, Issue 9882, 2013, Pages 1968-1970

  Crawford, Nigel W ^a   Graham, Steve M ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; EV71 VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; WART VIRUS VACCINE;

ASEPTIC MENINGITIS; CHICKENPOX; CHINA; DEATH; ENCEPHALITIS; ENTEROVIRUS 71; EPIDEMIC; GENOTYPING TECHNIQUE; HAND FOOT AND MOUTH DISEASE; HOSPITAL ADMISSION; IMMUNOGENICITY; MORBIDITY; MYOCARDITIS; NEGLECTED DISEASE; NEUROLOGICAL COMPLICATION; NOTE; PHARMACOLOGICAL PARAMETERS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROTAVIRUS; VACCINATION; WART VIRUS;

EID: 84878656757     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61124-1     Document Type: Note

References (13)

1. Zhu F-C, Meng F-Y, Li J-X, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; published online May 29. http://dx.doi.org/10.1016/S0140-6736(13)61049-1.
2. Qiu J. E nterovirus 71 infection: a new threat to global public health? Lancet Neurol 2008; 7: 868-69.
3. Xu J, Qian Y, Wang S, et al. EV71: an emerging infectious disease vaccine target in the Far East? Vaccine 2010; 28: 3516-21.
4. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10: 778-90.
5. Tan X, Huang X, Zhu S, et al. The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 2011; 6: e25662.
6. Lee M-S, Tseng F-C, Wang J-R, Chi C-Y, Chong P, Su I-J. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis 2012; 6: e1737.
7. Chinese CDC. National incidence and death cases of notifiable class A or class B infectious diseases (2008-10). http://www.chinacdc.cn (accessed May 14, 2013).
8. Seiff A. Cambodia unravels cause of mystery illness. Lancet 2012; 380: 205.
9. Zhu F-C, Liang Z-L, Li X-L, et al. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 2013; 381: 1037-45.
10. Lin T-Y, Kao H-T, Hsieh S-H, et al. Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J 2003; 22: 889-95.
11. Marshall HS, McIntyre P, Richmond P, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes following introduction of varicella vaccine in Australia. Pediatr Infect Dis J 2012; published online Dec 17. DOI:10.1097/INF.0b013e31827e92b7.
12. Donauer S, Payne DC, Edwards KM, et al. Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs. Vaccine 2013; published online April 12. DOI:10.1016/j.vaccine.2013.03.072.
13. Burche tt HED, Mounier-Jack S, Griffiths UK, Mills AJ. National decision-making on adopting new vaccines: a systematic review. Health Policy Plan 2012; 27 (suppl 2): ii62-76.